Navigation Links
Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
Date:6/27/2012

BEDFORD, Mass., June 27, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that its Selenia Dimensions breast tomosynthesis (3D), Selenia (2D) and Selenia Dimensions (2D) mammography systems placed first, second and third, respectively, in the digital mammography category in the  KLAS annual survey of healthcare executives and clinicians.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/hologic/50099/

(Photo: http://photos.prnewswire.com/prnh/20120627/MM29534)

For the "2012 Best in KLAS Awards: Medical Equipment & Infrastructure" report, over 100 medical equipment products were rated in more than 30 different categories. The Hologic Selenia Dimensions breast tomosynthesis system received the second highest overall performance score of the 10 Best in KLAS medical equipment categories and ranked first in its category. This is the third year in a row and the fourth time since KLAS began these evaluations in 2007 that a Hologic mammography system has been ranked in the highest position in the category.

"Vendors who are recognized with a Best in KLAS award are those who have gone above and beyond their customers' expectations. The goal and the value of the awards is to ultimately help providers and the industry easily identify which vendors are consistently performing well," said Adam Gale, president of KLAS.

In their March 2012 report* on the market for women's imaging equipment, the KLAS researchers noted that "Hologic is the clear leader in the breast imaging market and hits it out of the park with new technology—tomosynthesis. Even Hologic customers who are not using tomosynthesis see the company in a positive light because Hologic has developed and successfully delivered tomosynthesis to the space. ... For providers looking at digital mammography, Hologic is an obvious place to turn."

"For many years Hologic's digital mammography systems have been the systems of choice in the U.S. and in many other countries of the world," said Peter Soltani, Hologic Senior Vice President and General Manager, Breast Health. "Taking the top three places for digital mammography in the 2012 Best in KLAS awards represents a new milestone for our Company and shows the high regard users of our equipment have for Hologic breast imaging products."

"The industry considers KLAS a leading voice regarding medical equipment, helping customers and purchasing agents understand which products are preferred by users," said Soltani. "We are particularly pleased by the way the industry has accepted our newest technology - our breast tomosynthesis system. Research shows that breast cancer screening with Selenia Dimensions breast tomosynthesis finds many more cancers than conventional 2D mammography and gives radiologists the confidence to significantly reduce their recall rates."

About KLASKLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS' mission is to improve healthcare delivery by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors.

About Hologic, Inc. Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Forward Looking Statement Disclaimer This News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic digital mammography systems. There can be no assurance the systems will achieve the benefits described herein and that such benefits will be replicated in any particular manner with respect to an individual patient as the actual effect of the use of the systems can only be determined on a case-by-case basis depending on the particular circumstances and patient in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based.

Hologic, Dimensions and Selenia are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

*KLAS, "Women's Imaging 2012: Tomosynthesis Makes a Splash," May 2012© 2012 KLAS Enterprises,LLC www.KLASresearch.com

Contacts:Pat Hall

Olga KaragiannisCorporate Communications, Director

Sr. Global Publicity & Advertising, SpecialistHologic, Inc.

Hologic, Inc.Pat.Hall@Hologic.com

Olga.Karagiannis@Hologic.com Tel: +1 781 999 7463

Tel: +1 781 761 7069
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
2. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
5. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
6. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
7. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
8. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
10. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
11. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):